UPS introduces new cold chain container

UPS has announced it will offer a new air freight container for healthcare products, as the company aspires to reach a new level of shipment monitoring and product protection for temperature-sensitive pharmaceuticals, vaccines and biologics.

Only available through UPS, the PharmaPort 360 addresses a key industry issue of safeguarding healthcare shipments in the supply chain by enabling near real-time monitoring and maintaining product temperatures in extreme outside conditions.

"Amid the tremendous surge of temperature-sensitive therapies coming to market, it’s critical to have the most reliable solutions in place to help ensure the safe supply of healthcare products while also driving cost and operational efficiencies for healthcare manufacturers," said Mark Davis, product manager, UPS Healthcare Logistics. "The stakes are high when there’s a patient at the end of the supply chain, and UPS strongly believes that the PharmaPort 360 will ensure better protection of potentially life-saving therapies."

The PharmaPort 360 container manufactured by Cool Containers for UPS, maintains strict temperatures by utilising both heating and cooling storage technology, allowing it to tolerate a significantly wider range of extreme ambient temperature changes. The container more effectively maintains temperatures critical for protecting medicines that need to stay within the required 2-8°C to prevent spoilage. The PharmaPort 360 also sustains its protective temperature range for more than 100 hours, which is an important factor as more supply chains extend globally and healthcare products need to travel farther to reach markets.

The container’s temperature control and monitoring systems are powered by an AC rechargeable battery. The unit’s technology replaces the need for dry ice, thus eliminating the associated handling fees and hazardous materials charges. Also, the PharmaPort 360 will hold critical 2-8°C temperatures 38% longer than current dry ice container solutions.

The PharmaPort 360’s design also allows for more flexibility for flight options. While in transit mode, the container neither consumes energy nor emits external heat, vapour or gasses, allowing the unit to fly in both upper and lower deck aircraft positions. This offers more routing options, especially in constrained transportation lanes. The Federal Aviation Authority also has approved the PharmaPort 360 to fly on both narrow-body and wide-body aircraft, allowing for a high degree of flexibility in flight selections and opening access to markets globally.

Quelle: eyefortransport
Portal: www.logistik-express.com